(function(){var loadHandler=window['sl_{656BC694-C0A1-4D3A-883A-292145561588}'];loadHandler&&loadHandler(19, '<div id="spr0_3a3d2ff"><div id="spr1_3a3d2ff" class="kern slide"><img id="img0_3a3d2ff" src="data/img5.png" width="1280px" height="720px" alt="" style="left:0px;top:0px;"/><div id="svg6_3a3d2ff" style="left:49.06px;top:94.123px;"><svg width="1182" height="3" viewBox="-1.333 -0.667 1182 3"><g fill="#c2b6ab" stroke="none"><path stroke="#c2b6ab" stroke-width="1.333" stroke-linecap="butt" transform="translate(-50.393677,-94.789497)" d="M50.394,95.456 H1229.606"/></g></svg></div><div id="svg9_3a3d2ff" style="left:49.06px;top:94.123px;"><svg width="1182" height="3" viewBox="-1.333 -0.667 1182 3"><g fill="#cdd7dc" stroke="none"><path stroke="#cdd7dc" stroke-width="1.333" stroke-linecap="butt" transform="translate(-50.393677,-94.789497)" d="M50.394,95.456 H1229.606"/></g></svg></div></div><div id="spr2_3a3d2ff" class="kern slide"><div id="spr3_3a3d2ff" style="left:50.394px;top:18.898px;"><div style="width:0px;"><span id="txt0_3a3d2ff" data-width="284.645844" style="top:-0.696px;">Oxford database</span></div></div><div id="spr4_3a3d2ff" style="left:50.394px;top:114.354px;"><div style="width:0px;"><span id="txt1_3a3d2ff" data-width="1110.195313" style="top:1.899px;">Performed PSM to estimate HR for adverse events according to grades for ToxNav and Routine practice</span></div><div style="width:0px;"><span id="txt2_3a3d2ff" data-width="118.125000" style="top:40.299px;">strategies:</span></div><div style="width:0px;"><span id="txt3_3a3d2ff" class="nokern relpos" dir="auto" style="top:81.023px;">•</span> <span id="txt4_3a3d2ff" class="relpos" data-width="270.651031" style="left:18.997px;top:81.147px;">Rate of adverse events:</span></div><div style="width:0px;"><span id="txt5_3a3d2ff" class="nokern relpos" dir="auto" style="left:28.333px;top:119.423px;">•</span> <span id="txt6_3a3d2ff" class="relpos" data-width="458.684875" style="left:47.331px;top:119.547px;">haemoglobin Grade 1-2 and Grade 3-4;</span></div><div style="width:0px;"><span id="txt7_3a3d2ff" class="nokern relpos" dir="auto" style="left:28.333px;top:157.823px;">•</span> <span id="txt8_3a3d2ff" class="relpos" data-width="441.093750" style="left:47.331px;top:157.947px;">neutrophils Grade 1-2 and Grade 3-4;</span></div><div style="width:0px;"><span id="txt9_3a3d2ff" class="nokern relpos" dir="auto" style="left:28.333px;top:196.223px;">•</span> <span id="txt10_3a3d2ff" class="relpos" data-width="428.190094" style="left:47.331px;top:196.347px;">white cells Grade 1-2 and Grade 3-4;</span></div><div style="width:0px;"><span id="txt11_3a3d2ff" class="nokern relpos" dir="auto" style="left:28.333px;top:234.623px;">•</span> <span id="txt12_3a3d2ff" class="relpos" data-width="450.169250" style="left:47.331px;top:234.747px;">temperature Grade 1-2 and Grade 3-4.</span></div><div style="width:0px;"><span id="txt13_3a3d2ff" class="nokern relpos" dir="auto" style="top:273.023px;">•</span> <span id="txt14_3a3d2ff" class="relpos" data-width="1147.044189" style="left:18.997px;top:273.147px;">The risk of adverse events by type and grade is used in the Markov model only to estimate the dis-</span></div><div style="width:0px;"><span id="txt15_3a3d2ff" data-width="600.104126" style="left:28.333px;top:308.977px;">utilities accrued by patients related to these events.</span></div></div></div></div>', '{"s":[]}');})();